Carter, PA
Anna Carter, Harrisburg, PA US
Patent application number | Description | Published |
---|---|---|
20120280013 | GPS HOLDING DEVICE - The present invention is a GPS holding device for a motorcycle that includes a generally rectangular base with a tab and an aperture disposed on the tab, a bracket with a tab and an aperture disposed on the tab to secure the base to the device and a fastener that is placed through the apertures to secure the bracket to the base. The device is made of metal and has a powder coating covering the base and the bracket and a protective case to cover and protect the device. The holding device can also be used to secure a cell phone. | 11-08-2012 |
Charles Mcclean Carter, Lafayette Hill, PA US
Patent application number | Description | Published |
---|---|---|
20090008919 | Vehicle occupant restraint and method - A component of a vehicle occupant restraint system, the vehicle occupant restraint system having a webbing with a lap belt portion and a shoulder belt portion contiguous with the lap belt portion, the component including a web engaging device adapted to toggle between an open and an engaged condition, wherein in the open condition the webbing is moveable relative to the web engaging device in two directions along the webbing, wherein in the engaged condition the webbing is moveable relative to the web engaging device in only one direction along the webbing, and wherein the web engaging device is lockable in the open condition. A vehicle occupant restraint system including a webbing with lap and shoulder belt portions, a component having a web engaging device adapted to toggle between an open and an engaged condition, and a tensioner configured to respond to at least one of the open and engaged conditions. | 01-08-2009 |
Craig Carter, Macungie, PA US
Patent application number | Description | Published |
---|---|---|
20110301206 | SYNERGISTIC PRESERVATIVE BLENDS - The present invention is a preservative formulation which includes a combination of at least two (2) compounds having bactericidal and/or fungicidal properties wherein the at least two (2) compounds is selected from the group consisting of methylisothiazolinone/piroctone olamine; caprylyl glycol/dehydroacetic acid; undecanol/dehydroacetic acid and lauryl alcohol/sorbic acid. The invention also includes preparations including such combination as well as a method of using the combination to reduce bacterial and fungal load of preparations. | 12-08-2011 |
Douglas Scott Carter, Valencia, PA US
Patent application number | Description | Published |
---|---|---|
20150226486 | REFRACTORY INSULATING MODULE - Refractory modules and other insulating modules, which include a plurality of insulating module layers arranged with their major surfaces in a side-by-side orientation, are provided. Each insulating module layer includes a first section having a slot extending into a joint edge and a second section having a tab extending from a joint edge. The first and second sections each comprise a refractory insulation material, which typically includes a fibrous refractory material. The tab has an outer contour and the slot has an inner contour which substantially corresponds in shape such that when the tab is inserted in interlocking engagement into the slot, the joint edges of the first and second sections are held in juxtaposition along a section juncture. | 08-13-2015 |
Duane H. Carter, Irwin, PA US
Patent application number | Description | Published |
---|---|---|
20080202528 | Pressure Support System with Automatic Comfort Feature Modification - A pressure support system that delivers a flow of gas to a patient's airway via a pressure generating system and a patient circuit. A controller receives a treatment set point from an input source and determines an adjusted treatment set point based on the treatment set point and a comfort feature function, which in one embodiment, is not based on a physiological condition of such a patient. In another embodiment, the controller provides a respiratory treatment therapy during a therapy session based on the treatment set point and the comfort feature, which is modified automatically during a therapy session without user intervention based on a comparison of the treatment set point to a treatment set point variable. The controller controls the operation of the pressure generating system based on the adjusted treatment set point or the combination of the treatment set point and the comfort feature. | 08-28-2008 |
20080216832 | Pressure Support Method with Automatic Comfort Feature Modification - A method of delivering a flow of gas to a patient's airway via a pressure generating system and a patient circuit. A controller receives a treatment set point from an input source and determines an adjusted treatment set point based on the treatment set point and a comfort feature function, which in one embodiment, is not based on a physiological condition of such a patient. In another embodiment, the controller provides a respiratory treatment therapy during a therapy session based on the treatment set point and the comfort feature, which is modified automatically during a therapy session without user intervention based on a comparison of the treatment set point to a treatment set point variable. The controller controls the operation of the pressure generating system based on the adjusted treatment set point or the combination of the treatment set point and the comfort feature. | 09-11-2008 |
20090099471 | Disordered Breathing Monitoring Device And Method Of Using Same Including A Study Status Indicator - An apparatus and associated method for collecting data for a sleep study. The apparatus includes a sensor adapted to collect data relating to a parameter of a user of the apparatus over a period of time, and a controller operatively coupled to the sensor. The controller is adapted to: (a) receive configuration information specifying a predetermined amount of valid data that is required for a sleep study to be deemed valid, (b) receive the data relating to the parameter and determine an amount of the received data that is valid, and (c) cause a study status indicator to be output by the apparatus based on the amount of the received data that is determined to be valid and the predetermined amount specified in the configuration information. | 04-16-2009 |
Eric Carter, Camp Hill, PA US
Patent application number | Description | Published |
---|---|---|
20140261048 | RAIL CAMP - A rail vehicle includes a frame, a pair of wheels, a joint locator, a clamping assembly, and a processor. The wheels travel along a rail. The joint locator detects a joint bar on the rail. The clamping assembly is coupled to the frame and includes a pair of rail clamps disposed laterally outward of the pair of wheels. The processor is configured to automatically actuate the clamping assembly when the clamping assembly reaches the joint bar. | 09-18-2014 |
Frank C. Carter, Wormleysburg, PA US
Patent application number | Description | Published |
---|---|---|
20100076420 | Evacuation chamber - During cryotherapy, using an endoscope that extends within a patient to a cold treatment site, the device of the invention vacuums gas from the site through radial intake ports to a cylindrical space in an evacuation chamber held elastically circumferentially about the distal end of the endoscope tube that carries the cryoprobe to the site. | 03-25-2010 |
Franklin Carter, Harrisburg, PA US
Patent application number | Description | Published |
---|---|---|
20120280013 | GPS HOLDING DEVICE - The present invention is a GPS holding device for a motorcycle that includes a generally rectangular base with a tab and an aperture disposed on the tab, a bracket with a tab and an aperture disposed on the tab to secure the base to the device and a fastener that is placed through the apertures to secure the bracket to the base. The device is made of metal and has a powder coating covering the base and the bracket and a protective case to cover and protect the device. The holding device can also be used to secure a cell phone. | 11-08-2012 |
Jerry A. Carter, Clarks Green, PA US
Patent application number | Description | Published |
---|---|---|
20090043553 | Design Tool for Identifying Project Energy Interdependencies - A simulation system [ | 02-12-2009 |
20090057017 | Multiple Pulsejet Boring Device - A method and device for boring a hole [ | 03-05-2009 |
20090071713 | System for Rapidly Boring Through Materials - The present invention is a self-contained, high-energy liquid rock-boring system that will bore a small-diameter access hole [ | 03-19-2009 |
20090090553 | Command and Control for Boring System - A system having a number of land units [ | 04-09-2009 |
Lindsay L. Carter, Wayne, PA US
Patent application number | Description | Published |
---|---|---|
20120184986 | Vein Filter - A vessel filter having a first region and a second region, the filter movable between a collapsed position for delivery to the vessel and an expanded position for placement within the vessel. The first region has a filter portion having a converging region to direct particles toward the center of the filter and includes a plurality of spaced apart filter struts. The struts each have a strut height defined as a distance between a first wall and a second wall. A plurality of hooks are at the second region, the hooks having a vessel penetrating tip and a width greater than the width of the strut from which it extends such that the penetrating tip portion of the hook extends beyond the first wall. | 07-19-2012 |
20130178890 | VEIN FILTER - A vessel filter comprising a first region and a second region wherein the filter is movable between a collapsed position for delivery to the vessel and an expanded position for placement within the vessel. A first region has a filter portion having a converging region to direct particles toward the center of the filter and the second region is flared in the expanded position to have a transverse dimension increasing toward a second end portion opposite the first end portion. The second region includes a vessel engaging portion at the second end portion. The first region includes a plurality of spaced apart elongated struts with adjacent struts being joined. | 07-11-2013 |
20140066972 | VESSEL FILTER - A vessel filter having a first region and a second region, the filter movable between a collapsed position for delivery to the vessel and an expanded position for placement within the vessel. The first region has a filter portion having a converging region to direct particles toward the center of the filter and includes a plurality of spaced apart filter struts. The struts each have a strut height defined as a distance between a first wall and a second wall. A plurality of hooks are at the second region, the hooks having a vessel penetrating tip and a width greater than the width of the strut from which it extends such that the penetrating tip portion of the hook extends beyond the first wall. | 03-06-2014 |
Lititia Carter, York, PA US
Patent application number | Description | Published |
---|---|---|
20150108686 | CLOTH-LIKE SYNTHETIC TEXTILES - An embossing and texturizing system for imparting a natural cloth-like surface to a flexible thermoplastic material or film simultaneously to either or both of its two exterior surfaces, through the use of a device and technique combining metal rolls, metal and rubber rolls, and embossing and texturizing fabric rolls into an embossing system creating the desired visual and tactile feel of natural fabrics as well as additional performance characteristics. The embossing and texturizing system embosses and texturizes the exterior surface of the flexible thermoplastic material or film by selectively altering the exterior surface, and therefore, the film can be embossed simultaneously on either or both of its two exterior surfaces (face and reverse). The use of the embossing and texturizing mechanism and its alignment to the core and stabilizing reinforcing substrate enables the exterior texturized surface and the bottom side exterior texturized surface to be identical in all manner. | 04-23-2015 |
Matthew K. Carter, Fountainville, PA US
Patent application number | Description | Published |
---|---|---|
20100005039 | Apparatus and methods for isolating and reviewing data from multiple sources - Methods, apparatus and articles of manufacture are disclosed for isolating and reviewing data. The data is provided via a data source, and subsequently a rule may be provided, as well as a metaphor, to a user for perception of said metaphor via a user interface. | 01-07-2010 |
20140101089 | APPARATUS AND METHODS FOR ISOLATING AND REVIEWING DATA FROM MULTIPLE SOURCES - Methods, apparatus and articles of manufacture are disclosed for isolating and reviewing data. The data is provided via a data source, and subsequently a rule may be provided, as well as a metaphor, to a user for perception of said metaphor via a user interface. | 04-10-2014 |
Michael K. Carter, Horsham, PA US
Patent application number | Description | Published |
---|---|---|
20110303703 | APPARATUS FOR DISPENSING A CONTROLLED DOSE - An apparatus for dispensing a controlled dose of a substance wherein the apparatus includes a compressible tube portion, a tip portion extending from the tube portion sized to receive a substance to be dosed, and a breakaway portion being removably coupled to the tip portion. The breakaway portion reveals an aperture in the tip portion upon removal of the breakaway portion. Finally, a valve member is slidably disposed in the tip portion such that the valve member can be movable in response to fluid pressure and/or manual force application to urge the substance within the tip portion out of the aperture as a controlled dose. | 12-15-2011 |
Rahman Carter, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20100288085 | MIG WELDING PLIERS - An improved MIG welding pliers is disclosed, which allows faster and easier removal of spatter form a MIG welding nozzle, thereby improving welder productivity. Embodiments of the present invention provide a rounded file on the outer surface of each of the pinchers of the pliers. In one embodiment, each pincher has a different file surface. The rounded file surface provides for improved spatter removal, and eliminates the need for waxes and spatter control products which degrade the contact tip and nozzle, hastening the need for their replacement. Therefore, embodiments of the present invention increase the efficiency of a MIG welding operation, as less time is spent removing spatter from nozzles, and thus, more time is available for welding. Furthermore, by avoiding the use of waxes, costs are reduced since nozzles and contact tips do not need to be replaced as frequently. | 11-18-2010 |
Raymond Martin Carter, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20140046284 | DISPOSABLE ABSORBENT PRODUCT WITH TEMPORARY ADHESIVE ATTACHMENT AND RELATED METHODS - A disposable absorbent product extends longitudinally along a longitudinal axis and laterally along a transverse axis, with the transverse axis conceptually dividing the product into first and second hemispheres. The product has a permeable topsheet, an impermeable backsheet overlaying the topsheet, and an absorbent core disposed between the topsheet and the backsheet for storing fluid secreted by the wearer of the disposable absorbent product. Each of a pair of side regions extends laterally outboard of the absorbent core, with each side region having a first face configured to face the wearer during use and a second face opposite the first face. The product also has at least one skin-friendly adhesive element in the first hemisphere in at least one of the side regions for temporarily attaching the disposable absorbent product to the skin of the wearer. | 02-13-2014 |
20140135722 | DISPOSABLE ABSORBENT PRODUCT WITH DETECTABLE INODOROUS COMPONENT, AND SYSTEMS INCLUDING SAME - A disposable absorbent product includes a topsheet, a backsheet overlaying the topsheet, and an absorbent core disposed between the topsheet and the backsheet for absorbing fluid secreted by a wearer of the product. The product also includes a wetness indicating material in the topsheet, the backsheet, or the absorbent core, with the wetness indicating material having a water-soluble element and an inodorous component trapped by the water-soluble element. The water-soluble element is configured to degrade in the presence of fluid secreted by the wearer of the product, thereby releasing the inodorous component into the surrounding air. | 05-15-2014 |
Richard B. Carter, Washington Crossing, PA US
Patent application number | Description | Published |
---|---|---|
20080260791 | Injectable capsaicin - The present invention provides compositions and methods for relieving pain at a site in a human or animal in need thereof by administering at a discrete site in a human or animal in need thereof a dose of capsaicin in an amount effective to denervate a discrete site without eliciting an effect outside the discrete location, the dose of capsaicin ranging from 1 μg to 3000 μg. | 10-23-2008 |
20080262091 | Infiltration of capsaicin into surgical sites and open wounds - The present invention provides compositions and methods for attenuating or relieving pain at a site in a human or animal in need thereof by infiltrating at a surgical site or open wound in a human or animal a dose of capsaicinoid in an amount effective to denervate the surgical site or open wound substantially without eliciting an effect outside the surgical site or open wound. | 10-23-2008 |
20090054527 | Administration of capsaicinoids - Disclosed in certain embodiments is a method for relieving pain at a site in a human or animal in need thereof, comprising administering by injection or infiltration, a dose of a capsaicinoid and coadministering a vasodilator. | 02-26-2009 |
20090062359 | Injectable capsaicin with non-local anesthetic sodium channel-blocker adjunctive agent - Disclosed in certain embodiments is a method for relieving pain at a site in a human or animal in need thereof, comprising administering by injection or infiltration, a dose of a capsaicinoid and coadministering a non-anesthetic sodium channel blocker. | 03-05-2009 |
20090111792 | Injectable capsaicin with tricyclic antidepressant adjunctive agent - Disclosed in certain embodiments is a method for relieving pain at a site in a human or animal in need thereof, comprising administering by injection or infiltration, a dose of a capsaicinoid and coadministering a tricyclic antidepressant. | 04-30-2009 |
20090117167 | Injectable capsaicin with vasocontrictor adjunctive agent - Disclosed in certain embodiments is a method for relieving pain at a site in a human or animal in need thereof, comprising administering by injection or infiltration, a dose of a capsaicinoid and coadministering a vasoconstrictor. | 05-07-2009 |
20090118242 | Injectable capsaicin with non-steroidal anti-inflammatory adjunctive agent - Disclosed in certain embodiments is a method for relieving pain at a site in a human or animal in need thereof, comprising administering by injection or infiltration, a dose of a capsaicinoid and coadministering an effective amount of a NSAID to decrease an undesired effect of the capsaicinoid. | 05-07-2009 |
20130303620 | Injectable Capsaicin - The present invention provides compositions and methods for relieving pain at a site in a human or animal in need thereof by administering at a discrete site in a human or animal in need thereof a dose of capsaicin in an amount effective to denervate a discrete site without eliciting an effect outside the discrete location, the dose of capsaicin ranging from 1 μg to 3000 μg. | 11-14-2013 |
Richard Henry Carter, Merion Station, PA US
Patent application number | Description | Published |
---|---|---|
20120127821 | Method For Mixing Liquid Samples In A Container Using A Lemniscate Stirring Pattern - A method for rapidly and uniformly mixing solutions within a biochemical analyzer by rapidly and repeatedly moving a sampling probe in generally lemniscate shaped pattern within the solution is provided. | 05-24-2012 |
Scott C. Carter, Exton, PA US
Patent application number | Description | Published |
---|---|---|
20120142537 | SUPERCONDUCTING DIRECT CURRENT TRANSMISSION SYSTEM - A DC superconducting coaxial transmission system provides electrical transmission of 5,000 megawatts of energy while simultaneously delivering liquid hydrogen. The transmission system includes a coaxial transmission segment including an inner superconductor, an outer superconductor disposed in surrounding relation to the inner conductor, and a dielectric insulator disposed between the inner superconductor and the outer superconductor. Liquid hydrogen surrounds the superconductors. Three phase transformers and poly phase rectifier/inverters provide a DC voltage source to the superconductors from the electrical grid. In one embodiment, a switching circuit connected between the voltage source and the superconductor injects a cancellation current component into the direct current flow. The cancellation current component is polarized to flow in a direction opposite to the direct current flow to produce a current zero, thus enabling safe interruption of the high DC current while minimizing the magnitude of transient voltages during switching. | 06-07-2012 |
20140309117 | SUPERCONDUCTING DIRECT CURRENT TRANSMISSION SYSTEM - A DC superconducting coaxial transmission system provides electrical transmission of 5,000 megawatts of energy while simultaneously delivering liquid hydrogen. The transmission system includes a coaxial transmission segment including an inner superconductor, an outer superconductor disposed in surrounding relation to the inner conductor, and a dielectric insulator disposed between the inner superconductor and the outer superconductor. Liquid hydrogen surrounds the superconductors. Three phase transformers and poly phase rectifier/inverters provide a DC voltage source to the superconductors from the electrical grid. In one embodiment, a switching circuit connected between the voltage source and the superconductor injects a cancellation current component into the direct current flow. The cancellation current component is polarized to flow in a direction opposite to the direct current flow to produce a current zero, thus enabling safe interruption of the high DC current while minimizing the magnitude of transient voltages during switching. | 10-16-2014 |
Scott C. Carter, Morgantown, PA US
Patent application number | Description | Published |
---|---|---|
20140376132 | SYSTEM AND METHOD TO INTERRUPT A DC CURRENT IN A HIGH VOLTAGE CIRCUIT BY USE OF AN AC CIRCUIT BREAKER - An electrical circuit to interrupt a DC current includes a bypass switch and an AC high voltage breaker which includes interrupters that are rated for carrying a current having a value of the DC current for a period of time less than or equal to continuous duty. The first interrupter is electrically coupled in parallel with the bypass switch. A making switch causes a cancellation current to flow from an energy source through the second interrupter, and through the first interrupter, in addition to the DC current. The AC high voltage breaker is adapted to a DC service as the DC current in addition to the cancellation current causes an arc quench which allows the AC high voltage breaker to cause the interruption of the DC current in the electrical circuit. A method for interrupting a DC current flowing in an AC high voltage circuit breaker is also described. | 12-25-2014 |
William A. Carter, Spring City, PA US
Patent application number | Description | Published |
---|---|---|
20090004141 | Broad spectrum immune and antiviral gene modulation by oral interferon - An antiviral/immunomodulatory response in an animal is induced by oral administration to an infected animal, including humans, of a human α-interferon. Methods of conferring resistance or mitigating the effects of exposure to a virus including avian influenza are described. | 01-01-2009 |
20090304630 | Treating severe and acute viral infections - Severe acute respiratory syndrome is treated with a natural human alpha interferon, a dsRNA or both natural human alpha interferon and a dsRNA. Avian influenza is treated with natural human alpha interferon, neuraminidase inhibitor(s) and ribavirin. Effects of influenza virus are mitigated with a dsRNA in combination with a neuraminidase influenza virus inhibitor. These two products, dsRNA, and alpha interferon, have therapeutic utility either given preventively (prophylactically) or in treatment of active disease. These unique immunological/antiviral actions, operating through immunological “cascades” ameliorates the lethal effects of viral mutation which, by causing resistance to commonly available drugs, greatly accelerates the death rate. For example, in 1918-1920, Avian Influenza caused the death of approximately 40 million people worldwide (ref. | 12-10-2009 |
20100104533 | EARLY INTERVENTION OF VIRAL INFECTION WITH IMMUNE ACTIVATORS - Symptoms of viral infection are mitigated by administering to a subject exposed to a virus a protective or symptom-mitigating amount of a dsRNA and continuing administration until the subject's symptoms have improved. | 04-29-2010 |
20100160413 | Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity - The invention relates to our discovery of a novel double-stranded ribonucleic acid (dsRNA) having specific biological activities, which includes acting as a selective agonist for activation of the Toll-like receptor 3. Its “rugged” molecular structure as measured by physico-chemical techniques is resistant to molecular unfolding (i.e., denaturation). This structure appears to be responsible for increased efficacy of dsRNA in therapeutic applications and improved biological activity (e.g., used as an immunoregulatory agent). Medicaments, processes for their manufacture, and methods for their use are provided herein. | 06-24-2010 |
20100310600 | SELECTIVE AGONIST OF TOLL-LIKE RECEPTOR 3 - A mismatched double-stranded ribonucleic acid, which is an agonist for Toll-like receptor 3 (TLR3), is used in vitro or in vivo as an antimicrobial agent, antiproliferative agent, and/or immunostimulant. Poly(l:C | 12-09-2010 |
20110044946 | GENETEC REGULATION OF HOST DEFENSE MECHANISMS BY MUCOSAL EXPOSURE TO NATURAL INTERFERON ALPHA SPECIES - A mixture of α-interferons (IFN-α) is used in vitro or in vivo as an antimicrobial agent or anticancer agent. It may be administered by topical application to oral or nasal, and/or buccal mucosa to combat the effects of infection by bacteria or protozoa, cancer, or other pathogenic disease process (e.g., autoimmune or neurodegenerative disease). | 02-24-2011 |
20110196020 | TREATMENT OF CHRONIC FATIGUE SYNDROME USING SELECTIVE AGONISTS OF TOLL-LIKE RECEPTOR 3 (TLR3) - A subset of human patients having chronic fatigue syndrome and impaired physical performance is treated using one or more different double-stranded ribonucleic acids (dsRNA) or other selective agonists of Toll-like receptor 3 (TLR3). | 08-11-2011 |
20120004290 | TREATING CHRONIC FATIGUE SYNDROME AND PROLONGED QT INTERVAL - Chronic fatigue syndrome and prolonged QT interval are treated using one or more different double-stranded ribonucleic acids (dsRNA). | 01-05-2012 |
20140170191 | NOVEL DOUBLE-STRANDED RIBONUCLEIC ACIDS WITH RUGGED PHYSICO-CHEMICAL STRUCTURE AND HIGHLY SPECIFIC BIOLOGIC ACTIVITY - A novel form of Rugged dsRNA with a unique composition and physical characteristics was identified with high specificity of binding to TLR3, which conveys an important range of therapeutic opportunities. Unlike the previous known antiviral Ampligen® (poly I, poly C12,U) the new and improved form (poly I, poly C | 06-19-2014 |
20140235841 | DOUBLE-STRANDED RIBONUCLEIC ACIDS WITH RUGGED PHYSICO-CHEMICAL STRUCTURE AND HIGHLY SPECIFIC BIOLOGIC ACTIVITY - The invention relates to our discovery of a novel double-stranded ribonucleic acid (dsRNA) having specific biological activities, which includes acting as a selective agonist for activation of the Toll-like receptor 3. Its “rugged” molecular structure as measured by physico-chemical techniques is resistant to molecular unfolding (i.e., denaturation). This structure appears to be responsible for increased efficacy of dsRNA in therapeutic applications and improved biological activity (e.g., used as an immunoregulatory agent). Medicaments, processes for their manufacture, and methods for their use are provided herein. | 08-21-2014 |
William A. Carter, Birchrunville, PA US
Patent application number | Description | Published |
---|---|---|
20120009206 | NOVEL DOUBLE-STRANDED RIBONUCLEIC ACIDS WITH RUGGED PHYSICO-CHEMICAL STRUCTURE AND HIGHLY SPECIFIC BIOLOGIC ACTIVITY - A novel form of Rugged dsRNA with a unique composition and physical characteristics was identified with high specificity of binding to TLR3, which conveys an important range of therapeutic opportunities. Unlike the previous known antiviral Ampligen® (poly I, poly C12,U) the new and improved form (poly I, poly C | 01-12-2012 |
20140335112 | NOVEL DOUBLE-STRANDED RIBONUCLEIC ACIDS WITH RUGGED PHYSICO-CHEMICAL STRUCTURE AND HIGHLY SPECIFIC BIOLOGIC ACTIVITY - A novel form of Rugged dsRNA with a unique composition and physical characteristics was identified with high specificity of binding to TLR3, which conveys an important range of therapeutic opportunities. Unlike the previous known antiviral Ampligen® (poly I, poly C12,U) the new and improved form (poly I, poly C | 11-13-2014 |